Contributions by role
Contributions by subject area
José G B Derraik
Summary
Dr José G B Derraik is a health researcher with expertise spanning several domains, including Public Health, Paediatrics, Medicine, Epidemiology, Environmental Health, Biosecurity, and Ecology. Notably, his experience covers a wide range of clinical studies, from cross-sectional studies to randomised controlled trials, involving children, adolescents, and adults (including pregnant women). Other primary research areas are Epidemiology and Paediatrics, with a specific focus on the Developmental Origins of Health and Disease (DOHaD), which delves into the associations between early life events and their short- and long-term health implications.
One of Derraik's key strengths is fostering effective and harmonious international collaborations. He currently collaborates with colleagues from many countries, including (in alphabetical order) Australia, Brazil, China, Ireland, Italy, Singapore, Sweden, Switzerland, UK, and Thailand. In 2017, Uppsala University in Sweden appointed him as an invited researcher in their Dept of Women's & Children's Health, through which he has co-authored several studies on the long-term associations with early life events, utilizing extensive datasets from the Swedish Birth Register and Swedish Conscript Register. In 2018, he was appointed an Honorary Associate Professor at the Children's Hospital of Zhejiang University School of Medicine in Hangzhou, China, a hospital that stands as only the second National Clinical Research Centre for Child Health in that country. Additionally, in Thailand, he has been serving as a Visiting Professor at the Research Institute for Health Sciences at Chiang Mai University since 2021. Derraik's role includes co-leading the long-term follow-up of a birth cohort in Chiang Mai, with the 30-year follow-up recently concluded.
Worth highlighting is Derraik's expertise in the data analysis of clinical studies, having played a pivotal role in over 170 peer-reviewed publications. His professional journey has also included the public sector, where he served as a senior advisor for MAF Biosecurity New Zealand. In this capacity, he offered expert technical counsel to the NZ Government and the Minister of Biosecurity on public health concerns. Lastly, he’s always eager to grow and learn, having recently embarked on understanding how artificial intelligence (AI) can enhance the precision and efficiency of his work. He is currently delving into several generative AI tools to optimise both efficiency and quality of his research.
Clinical Trials Diabetes & Endocrinology Epidemiology Evidence Based Medicine Global Health Pediatrics Public Health